Drugs / acetylsalicylic acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT03560310 Comparator | Jun 2018 → Mar 2025 overdue | acute coronary syndrome | Vastra Gotaland Region | Active not recruiting | Missed primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | acetylsalicylic acid | “dual antiplatelet therapy with acetylsalicylic acid (ASA) and ticagrelor is superior to only ASA after isolated coronary artery bypass grafting (CABG) in patients with acute...” PMID 36681173 ↗ Jan 2023 |
| Known as | ASA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03560310 ↗ |